Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.221.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.242ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.242ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.242ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.242NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.449ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.449ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.449ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.449NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.152ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.152ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.152ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.152NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.146ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.146ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.146ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.146NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
D.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
D.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
D.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.81ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.81NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.160.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.177.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.177.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.445ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.1.445ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.445NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used